Immunogen, Inc. (IMGN) Misses Q4 EPS by 51c
Get Alerts IMGN Hot Sheet
Price: $31.25 --0%
Revenue Growth %: -100.0%
Financial Fact:
Total operating expenses: 46.5M
Today's EPS Names:
WF, CWBC, GLTO, More
Revenue Growth %: -100.0%
Financial Fact:
Total operating expenses: 46.5M
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
Immunogen, Inc. (NASDAQ: IMGN) reported Q4 EPS of ($0.83), $0.51 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $5.74 million versus the consensus estimate of $9.72 million.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Microsoft fiscal Q3 results top estimates as AI revolution spurs cloud growth
- Alphabet, Microsoft earnings; PCE data ahead - what's moving markets
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!